Javascript must be enabled to continue!
A phenomenological model of neuroimmune interactions in epileptogenesis
View through CrossRef
Abstract
Epilepsy can have many different causes and its development (epileptogenesis) involves a bewildering complexity of interacting processes. Here, we present a first-of-its-kind computational model to better understand the role of neuroimmune interactions in the development of acquired epilepsy. Our model describes the interactions between neuroinflammation, blood-brain barrier disruption, neuronal loss, circuit remodeling, and seizures. Formulated as a system of nonlinear differential equations, the model is validated using data from animal models that mimic human epileptogenesis caused by infection, status epilepticus, and blood-brain barrier disruption. The mathematical model successfully explains characteristic features of epileptogenesis such as its paradoxically long timescales (up to decades) despite short and transient injuries, or its dependence on the intensity of an injury. Furthermore, stochasticity in the model captures the variability of epileptogenesis outcomes in individuals exposed to identical injury. Notably, in line with the concept of degeneracy, our simulations reveal multiple routes towards epileptogenesis with neuronal loss as a sufficient but non-necessary component. We show that our framework allows for
in silico
predictions of therapeutic strategies, providing information on injury-specific therapeutic targets and optimal time windows for intervention.
Title: A phenomenological model of neuroimmune interactions in epileptogenesis
Description:
Abstract
Epilepsy can have many different causes and its development (epileptogenesis) involves a bewildering complexity of interacting processes.
Here, we present a first-of-its-kind computational model to better understand the role of neuroimmune interactions in the development of acquired epilepsy.
Our model describes the interactions between neuroinflammation, blood-brain barrier disruption, neuronal loss, circuit remodeling, and seizures.
Formulated as a system of nonlinear differential equations, the model is validated using data from animal models that mimic human epileptogenesis caused by infection, status epilepticus, and blood-brain barrier disruption.
The mathematical model successfully explains characteristic features of epileptogenesis such as its paradoxically long timescales (up to decades) despite short and transient injuries, or its dependence on the intensity of an injury.
Furthermore, stochasticity in the model captures the variability of epileptogenesis outcomes in individuals exposed to identical injury.
Notably, in line with the concept of degeneracy, our simulations reveal multiple routes towards epileptogenesis with neuronal loss as a sufficient but non-necessary component.
We show that our framework allows for
in silico
predictions of therapeutic strategies, providing information on injury-specific therapeutic targets and optimal time windows for intervention.
Related Results
Is the Neuroimmune System a Therapeutic Target for Opioid Use Disorder? A Systematic Review
Is the Neuroimmune System a Therapeutic Target for Opioid Use Disorder? A Systematic Review
Opioid use disorder (OUD) is an epidemic in the United States. In the past 12 months alone, there have been 75,000+ deaths attributed to opioid overdose: more than any other year i...
MicroRNAs and target genes in epileptogenesis
MicroRNAs and target genes in epileptogenesis
AbstractEpilepsy is a chronic brain dysfunction. Current antiepileptic medicines cannot prevent epileptogenesis. Increasing data have shown that microRNAs (miRNAs) are selectively ...
Unraveling a comparative landscape of protein-coding genes linked to neuroimmune function during adulthood consequent of prenatal alcohol exposure
Unraveling a comparative landscape of protein-coding genes linked to neuroimmune function during adulthood consequent of prenatal alcohol exposure
Abstract
Background
An overwhelming body of evidence suggests neuroimmune dysfunction as a key underlying mechanism of FASD-ass...
Who's Down With UDP?—Not Epilepsy; Purinergic Microglial Ca
2+
Signaling Mediates Epileptogenesis
Who's Down With UDP?—Not Epilepsy; Purinergic Microglial Ca
2+
Signaling Mediates Epileptogenesis
Purinergic mechanisms mediate microglial Ca
2
+
signal...
Neuroprotective and anti-inflammatory effects of Yingqiao San on epileptogenesis are mediated by inhibiting HMGB1 translocation and regulating the HMGB1/TLR4 signaling pathway
Neuroprotective and anti-inflammatory effects of Yingqiao San on epileptogenesis are mediated by inhibiting HMGB1 translocation and regulating the HMGB1/TLR4 signaling pathway
Abstract
Background: Epileptogenesis was the latency period of epilepsy. Neuronal damage and subsequent inflammatory response were the basic mechanisms of epileptogenesis. ...
Neuroimaging Biomarkers of Experimental Epileptogenesis and Refractory Epilepsy
Neuroimaging Biomarkers of Experimental Epileptogenesis and Refractory Epilepsy
This article provides an overview of neuroimaging biomarkers in experimental epileptogenesis and refractory epilepsy. Neuroimaging represents a gold standard and clinically transla...
Shape features of epileptic spikes are a marker of epileptogenesis in mice
Shape features of epileptic spikes are a marker of epileptogenesis in mice
SummaryPurposeTo identify reliable biomarkers for quantitatively assessing the development of epilepsy in brain.MethodsIn a kainate mouse model of temporal lobe epilepsy, we perfor...
The spatial architecture of neuroimmune interactions in epilepsy
The spatial architecture of neuroimmune interactions in epilepsy
Epilepsy is increasingly recognized as a disorder not only of neuronal dysfunction but also of immune dysregulation within the central nervous system (CNS). Accumulating evidence p...

